Molecular Imaging News and Research

RSS

Scientists identify early signs of Parkinson’s disease years before symptoms develop

Scientists have identified the earliest signs of Parkinson’s disease in the brain up to 20 years before patients present with any symptoms.

20 Jun 2019

Amsterdam University Medical Center wins MR Solutions’ Image of the Year 2019 award

The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular research image

From MR Solutions 12 Jun 2019

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Bruker Daltonics has launched a novel timsTOF fleX mass spectrometer which combines ESI/MALDI capability for SpatialOMx on a single instrument.

From Bruker Life Sciences Mass Spectrometry 10 Jun 2019

Novel radiotracer can identify nearly 30 types of malignant tumors

A novel class of radiopharmaceuticals has proven effective in non-invasively identifying nearly 30 types of malignant tumors, according to research published in the June issue of The Journal of Nuclear Medicine.

10 Jun 2019

New PET imaging platform can scan multiple animals while they are awake

Have you ever spent half an hour trying to take the best photo of your pets but they won't stay still in the perfect angle? This is also true for small animal imaging research using positron emission tomography.

31 May 2019

MR Solutions’ multi-modality, cryogen free technology seen to be game-changer at ISMRM meeting in Montreal

MR Solutions’ high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine, in Montreal last week.

From MR Solutions 31 May 2019

Deep learning analysis of SPECT MPI can improve diagnosis of coronary artery disease

A multicenter international study has demonstrated for the first time that diagnosis of obstructive coronary artery disease can be improved by using deep learning analysis of upright and supine single photon emission computed tomography myocardial perfusion imaging

29 May 2019

CUIMC selects MILabs for upgrades to its molecular imaging capabilities

The MILabs VECTor (OI/CT) system has been acquired by the Department of Radiology at Columbia University Irving Medical Center to upgrade its molecular imaging capabilities.

13 May 2019

Novel chemical probe enables live imaging of brain immune cells

Researchers in South Korea and Singapore have, for the first time, developed a chemical probe that enables live-imaging of a type of immune cells in the brain, known as microglia, in a live animal brain.

3 May 2019

PET images of microglial activation levels could better predict Alzheimer's disease progression

Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.

4 Apr 2019

Expanding range and functionality of radiotracers for improved disease diagnosis

Biomedical imaging has revolutionized medicine, granting doctors a window into miniscule molecular and cellular processes inside the body. An EU-funded project helped to expand the view, developing innovative radiochemistry concepts and techniques that could lead to earlier diagnosis of diseases - saving lives.

4 Apr 2019

Case studies explain the potential benefits of total-body PET/CT imaging

Case studies from the first total-body positron emission tomography/computed tomography (PET/CT) scanner reveal multiple benefits of the novel imaging technology, providing a solid groundwork upon which to build its clinical utility.

1 Apr 2019

Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology

Milabs B.V., manufacturer of the world’s only fully integrated SPECT/PET/Optical/CT-scanner, today announces that the core molecular imaging facility at Queen Mary University of London’s Barts Cancer Institute has boosted its radionuclide imaging capabilities with a MILabs VECTor PET/SPECT/CT omni-tomography system.

21 Mar 2019

New nuclear medicine tracers make it easier to diagnose and treat cancer

Researchers have identified two new nuclear medicine tracers that make it easier to diagnose and potentially treat cancer.

12 Mar 2019

Nuclear medicine imaging assesses melanoma patients' response to immunotherapy

Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome. In this way, a patient's therapy can be more effectively tailored to his or her personal response.

6 Mar 2019

MR Solutions to showcase latest multi-modality MRI systems at EMIM 2019

MR Solutions’ latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019.

From MR Solutions 28 Feb 2019

RWTH Aachen chooses MILabs’ hybrid OI/CT system to enhance molecular imaging research

RWTH Aachen University have chosen the MILabs high-resolution CT to further enhance its world-leading molecular imaging research.

26 Feb 2019

New PET/CT tracer shows high detection rate for diagnosis of acute venous thromboembolism

A first-in-human study featured in the February issue of The Journal of Nuclear Medicine reports that the novel positron emission tomography/computed tomography tracer 18F-GP1 showed excellent image quality and a high detection rate for the diagnosis of acute venous thromboembolism.

18 Feb 2019

Artificial intelligence can accurately predict prognosis of ovarian cancer patients

The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods. It can also predict what treatment would be most effective for patients following diagnosis.

15 Feb 2019

Researchers conduct extensive comparison of drugs used in treating neuroendocrine tumors

An increasing number of new anti-cancer drugs are made available each year. During the authorization process, such new drugs usually undergo comparisons to one, but only rarely to multiple established drugs.

14 Feb 2019